A groundbreaking study has shed light on the complex interactions between dystrophin, a protein critical to muscle stability, and its partner protein, dystrobrevin, offering new pathways for ...

Studies involving the selective restoration of membrane bound nNOS to dystrophin-deficient skeletal muscle will address some of these issues. In addition to shedding light on the function of the ...

A new study has shed light on the complex interactions between dystrophin, a protein critical to muscle stability, and its partner protein, dystrobrevin, offering new pathways for understanding and ...

Revidia Therapeutics Inc., a cardiac regenerative medicine company developing first-in-class small molecule drug therapies for heart injury, has announced that it has expanded its leadership team in ...

Newer therapies like PGN-EDO51 that target exon skipping are considered promising pathways to slow disease progression by restoring partial dystrophin function.

New study reveals crucial protein interactions in Duchenne Muscular Dystrophy, opening doors to more precise and effective ...

This is due to a fault in the gene producing dystrophin. Muscles to become weaker ... it affects the ability to breathe as well as the function of the heart, as the heart is a muscle too.

Capricor's biologics license application for deramiocel (CAP-1002) is draws largely on the Phase 2 HOPE-2 trial and its ...

Pfizer has reported that its Phase III CIFFREO clinical trial of investigational mini-dystrophin gene therapy ... no significant improvement in motor function was observed in the gene therapy ...